Growth hormone treatment and fat redistribution in children born small for gestational age

J Pediatr. 2008 Mar;152(3):327-30. doi: 10.1016/j.jpeds.2007.07.043. Epub 2007 Oct 22.

Abstract

Objective: To determine whether in children born small for gestational age (SGA) high-dose growth hormone (GH) treatment is not only associated with catch-up of growth and with gain of lean mass, but also with a more central fat distribution.

Study design: Short children who were SGA (n = 25; age [mean +/- SD], 5.3 +/- 1.5 years) were randomly assigned to remain untreated (n = 14) or to receive GH (n = 11; sc 66 mug/Kg/d). Growth status and body composition were assessed at the study's start, after 1 year, and after 2 years with anthropometry and absorptiometry.

Results: Children who were treated with GH gained more height and weight than children who were untreated and developed a less adipose body composition (all P < .0001), as expected. However, these changes were also accompanied by a relatively more centripetal distribution of fat mass (0-2 year change in ratio of trunk fat to limb fat; 0.26 +/- 0.23 versus 0.02 +/- 0.15; P < .0001).

Conclusion: In children who are SGA, catch-up growth induced by exogenous GH in high doses is accompanied by a less adipose body composition and a more central fat distribution.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Body Fat Distribution*
  • Body Mass Index
  • Child
  • Child, Preschool
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Growth Disorders / diagnosis
  • Growth Disorders / drug therapy*
  • Human Growth Hormone / adverse effects
  • Human Growth Hormone / therapeutic use*
  • Humans
  • Infant, Newborn
  • Infant, Small for Gestational Age*
  • Injections, Subcutaneous
  • Male
  • Probability
  • Reference Values
  • Risk Assessment
  • Statistics, Nonparametric
  • Treatment Outcome

Substances

  • Human Growth Hormone